GLI3 Antibody - FFPE Validated

Biological Background

Plan your comparisons around GLI3 and use this antibody to characterize state-dependent differences. GLI3 is a pathway component whose activation state and localization can change after stimulation. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

Tracking GLI3 can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Use in the Laboratory

Signaling targets are typically assessed across time courses to capture transient activation windows. Time course design can be decisive when regulation is transient or compartment dependent.

Interpreting changes can benefit from separating expression differences from redistribution, particularly when the target cycles between compartments.

To keep datasets interpretable, labs often document:

• interaction patterns within multi-protein complexes
• time-resolved changes following stimulation or inhibition
• localization shifts between cytoplasm, membrane, and nucleus

Version Notes

Because fixation can mask epitopes, fixed-section oriented formats aim to maintain recognition after standard deparaffinization and retrieval steps. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Predefine decision rules for excluding outliers so analysis remains transparent.

For challenging targets, pairing GLI3 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

When interpreting GLI3, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the fixed-section option to keep GLI3 analysis aligned with planned contrasts and endpoints.